PCM
OPTR

Prelude Capital Management’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Prelude Capital Management’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-15,118
Closed -$190K – 2236
2013
Q3 		$190K Buy
+15,118
New +$200K 0.03% 559

Prelude Capital Management's OPTR Position: Q4 2013 in Review

Prelude Capital Management sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 15,118 shares — an estimated $190K sold.

Prelude Capital Management first reported a position in OPTR in Q3 2013 and held it in 1 quarter. The position peaked at $190K in Q3 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • Prelude Capital Management reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • Prelude Capital Management sold 15,118 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $190K.
  • Prelude Capital Management first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q3 2013 and held it in 1 quarter.
  • Prelude Capital Management's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $190K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on Prelude Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.